Greece has announced that the price of certain drugs are to be reduced 10.41% and that it is drawing up a second list of medicines which will no longer be eligible for reimbursement.
The 10.41% retail price cuts announced by the economics ministry will be for a range of drugs used in the treatment of serious diseases, licensed for hospital use or prescribing by specialists only, and provisions will be put in place to enable patients to obtain them from pharmacies. The drugs involved have not been identified, but analysts at IHS Global Insight suggest that they will include biotechnology drugs used in the treatment of cancer, and possibly some orphan products. What is certain, they add, is that products whose prices are now to be cut will not be those which were included in the average 27% across-the-board price cut introduced by the government on a temporary basis in May.
Friday, August 20, 2010
More drug price cuts in Greece
via pharmatimes.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment